Paul Norwood, MD, leads the team at Valley Endocrine in Fresno, California. Valued by his community for his caring and kind personality as well as his skills as a physician, Dr. Paul Norwood is also respected nationwide for his expertise as an endocrinologist. In 1993, Dr. Norwood founded Valley Endocrine Clinic, which specializes in endocrinology, diabetes and metabolism, as well as Valley Research, which does clinical trials.
It’s easy to see that patients come first at Dr. Norwood’s busy practice. The friendly atmosphere and patient-focused philosophy provide a welcoming environment for men and women experiencing endocrine disorders.
Services offered at Valley Endocrine include comprehensive endocrinology consultations as well as evaluation and treatment for thyroid dysfunction, polycystic ovary syndrome (PCOS), hypertension, metabolic disorders, hypertension, hormone imbalance, cholesterol and lipid disorders, and diabetes.
Dr. Norwood’s dedication to helping men and women overcome endocrine-related medical issues is also apparent in his professional research regarding a faulty endocrine system and its effect on health and overall well-being. His work has been well received by his peers and published in numerous, highly respected medical journals.
Valley Endocrine is also the largest pharmaceutical research facility in the world for diabetes. Dr. Norwood is a committed partner in the mission to discover the best possible treatment for this sometimes difficult to manage condition.
He received his medical degree from Loma Linda University School of Medicine and finished an internship and internal medicine residency at the University of California, Irvine, and Veterans Affairs Long Beach Hospital. Dr. Norwood completed a fellowship in endocrinology at University of California, Davis.
Dr. Norwood and his staff are honored when men and women choose Valley Endocrine, where patients are treated as people rather just another appointment on the schedule.
VALLEY ENDOCRINE ENDOCRINOLOGISTS
550 E. Herndon Avenue, Suite 101
Fresno, CA 93720
Phone: (559) 306-6099
Valley Endocrine and Research
Direct clinical research and see patients with endocrine problems
June 1986 – Present
University of California at San Francisco
1991 – present, Associate Clinical Professor of Medicine
University of California, Davis
Fellowship in Endocrinology July 1984-June 1986
University of California, Irvine-Long Beach VA
Internship and Residency in Internal Medicine July 1981-June 1984
Loma Linda University
Doctor of Medicine (M.D.) December 1981
University of California, Santa Barbara
B.A. in Biology/Biological Sciences September 1977
Licenses & Certifications
State of California – License to practice as a physician and surgeon
American Board of Internal Medicine – Board Certified
Subspecialty in Endocrinology and Metabolism, November 1987
American Board of Internal Medicine, Board Certified
Specialty of Internal Medicine, November 1984
Medical Organization Memberships
Fellowship American College of Physicians
California Medical Association
Fresno-Madera Medical Association
Publications & Presentations
Diabetes – Safety of Exenatide once weekly in patients with Type II Diabetes treated with thiazolidinedione, 70th Scientific Session 2010, 715-P.
Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes, 2008 European Respiratory Journal 32: 180-188.
Randomized Study to Characterize Glycemic Control and Short-Term Pulmonary Function in Patients with Type 1 Diabetes Receiving inhaled insulin, 2007 Clinical Endocrinology & Metabolism (www.endojournals.org).
Inhaled Insulin: A Clinical Perspective with Emphasis of EXUBERA, May 2007 Expert Review of Endocrinology and Metabolism, Volume 2, No. 3, Pages 313-320.
Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels with Muraglitazar, a Dual Peroxisome Proliferator-Activated Receptor Activator, in Patients with Type 2 Diabetes In adequately controlled with Metformin Monotherapy, A double-bling, randomized, pioglitazone-comparative study, 2006 Diabetes Care 29:1016-1023.
Presentation at The European Association for the Study of Diabetes e.V. (EASD). Impressive Efficacy and Safety Results seen with Inhaled Insulin (Exubera) in Type I Diabetics (Doctors Guide to the Internet Presentation, September 13, 2005).
The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers, 2003 Diabetes Care 26:1701-1705 (2003 American Diabetes Association, Inc.).
Video: Dr. Paul Norwood M.D. of Valley Research discusses treatments and medicine to treat conditions like diabetes, chronic migraines, https://www.youtube.com/watch?v=-Ueoj-gOs5M